The Congressionally Directed Medical Research Programs (CDMRP) selects the PCCTC’s co-development of therapies and biomarkers as a 2015 Prostate Cancer Highlight.
Our services translate scientific discoveries into improved standards of care, ensuring efficient trial selection, reporting, site management, clinical operations and data analyses.